Open AccessWhat are the factors that affect post COVID 1st month's continuing symptoms?
Author(s) -
Akinci Ozyurek Berna,
Sahin Ozdemirel Tugce,
Akkurt Esma Sevil,
Yenibertiz Derya,
Saymaz Zeynep Tilbe,
Büyükyaylacı Özden Sertaç,
Eroğlu Zehra
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.14778
Subject(s) - medicine , myalgia , weakness , outpatient clinic , pediatrics , covid-19 , disease , physical therapy , surgery , infectious disease (medical specialty)
Aim The aim of our research was to investigate retrospectively the relationship between the symptoms and general characteristics, initial laboratory values and treatments in patients who had COVID‐19 and who applied to the chest diseases outpatient clinic for control after 1 month. Method Three hundred fifteen patients who were diagnosed with COVID‐19 and applied to the chest diseases outpatient clinic between May 2020 and August 2020 for control in the 1st month were included in the study. Patient information was collected from the hospital information system and the e‐pulse system. Results Females accounted for 50.2% of our patients and their mean age was 47.9 ± 14.8 (19‐88) years. About 14.3% (n: 45) of the individuals were 65 years of age and older, 20.6% (n: 65) of our patients were smoking and 70.2% (n: 221) of our patients were treated at home. A total of 133 patients had at least one comorbid disease. The patients most frequently reported cough, dyspnoea, weakness, myalgia and diarrhoea. The most common symptoms were cough, dyspnoea, weakness and myalgia in the 1st month. Initial D‐dimer, initial CRP and the values of platelet, D dimer and CRP in the 1st month were detected to be higher in patients with persistent symptoms when the laboratory values of patients whose symptoms continue after 1 month were examined. It was determined that the symptoms had persisted in patients who had been hospitalised, had dual therapy, had comorbid diseases and had more common pathologies in their pulmonary imaging. Conclusion Symptoms may persist for a long time in hospitalised patients, in patients with COVID‐19–related pneumonia and concomitant chronic diseases and in patients with high D‐dimer and high CRP at the time of admission. Patients are informed that their symptoms may last for a long time, unnecessary hospital admissions can be avoided.